A Phase 2 Randomized, Dose-blind, Multicenter Study to Evaluate the Safety and Efficacy of KZR-616 in the Treatment of Patients with Autoimmune Hemolytic Anemia and Immune Thrombocytopenia

Project: Research project

Project Details

Description

A Phase 2 Randomized, Dose-blind, Multicenter Study to Evaluate the Safety and Efficacy of KZR-616 in the Treatment of Patients with Autoimmune Hemolytic Anemia and Immune Thrombocytopenia
StatusActive
Effective start/end date8/20/198/30/24

Funding

  • KEZAR LIFE SCIENCES, INC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.